|
|
Commentaries |
| Systolic versus diastolic pressure: paradigm shift or cycle? |
477 |
| JD Swales
|
|
Full Article (PDF)
|
|
| Endothelial vasomotor dysfunction in hypertension |
481 |
| R Pedrinelli
|
|
Full Article (PDF)
|
|
Original Articles |
| Failure of L-arginine to induce hypotension in patients with a history of accelerated-malignant hypertension |
485 |
| K Sato,
M Kinoshita,
M Kojima,
K Miyagawa,
H Takase,
S Suzuki & Y Dohi
|
|
Abstract
Full Article (PDF)
|
|
| Blood pressure patterns and cardiovascular risk factors in rural and urban Gambian communities |
489 |
| MAB van der Sande,
PJM Milligan,
OA Nyan,
JTF Rowley,
WAS Banya,
SM Ceesay,
WMV Dolmans,
Th Thien,
KPWJ McAdam & GEL Walraven
|
|
Abstract
Full Article (PDF)
|
|
| Prevalence, awareness and management of hypertension in a recently urbanised community, eastern Jordan |
497 |
| HY Jaddou,
AM Bateiha & KM Ajlouni
|
|
Abstract
Full Article (PDF)
|
|
| Relationship between plasma renin profile and leptinaemia in patients with essential hypertension |
503 |
| M Adamczak,
F Kokot & A Wi cek
|
|
Abstract
Full Article (PDF)
|
|
| Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME Study |
511 |
| P Marques-Vidal,
M Montaye,
B Haas,
A Bingham,
A Evans,
I Juhan-Vague,
J Ferrières,
G Luc,
P Amouyel,
D Arveiler,
D McMaster,
JB Ruidavets,
J-M Bard,
PY Scarabin & P Ducimetière
|
|
Abstract
Full Article (PDF)
|
|
| Antihypertensive effect of Valyl-Tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects |
519 |
| T Kawasaki,
E Seki,
K Osajima,
M Yoshida,
K Asada,
T Matsui & Y Osajima
|
|
Abstract
Full Article (PDF)
|
|
| Effect of antihypertensive treatment on office and self-measured blood pressure: The Autodil Study |
525 |
| MJ Leeman,
RL Lins,
JE Sternon,
BC Huberlant & CE Fassotte
|
|
Abstract
Full Article (PDF)
|
|
Letter to the Editor |
| Central aortic blood pressure measurements |
531 |
| Christopher J Bulpitt,
C Rajkumar & James D Cameron
|
|
Full Article (PDF)
|
|
Corrigendum |
| Factors influencing the development of malignant hypertension in Nigeria |
532 |
| S Kadiri,
BO Olutade & O Osobamiro
|
|
Abstract
Full Article (PDF)
|
|
